Erectile dysfunction and cardiovascular diseases

Archivos Espanoles de Urologia

Volumn 63, Issue 8, 2010, Pages 649-654

  Wespes, E ^a   Schulman, C C ^b  

^a ERASME HOSPITAL   (Belgium)

^b Institut Cavell   (Belgium)

Author keywords

Atherosclerosis; Cardiovascular pathology; Endothelial dysfunction; Erectile dysfunction; PDE5 I

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; HUMAN; MALE; ORGANIC IMPOTENCE; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; IMPOTENCE, VASCULOGENIC; MALE;

EID: 78149237276     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Lue TF. Erectile dysfunction. New engl J Med 2000;342:1802-1813
2. Wespes E, Moreira de Goes P, Schulman CC. Vascular impotence: focal or diffuse penile disease. J Urol 1992;148:1435-1436
3. Feldman HA, Goldstein I, Hatzichristou D, Krane RJ, McKinlay JB. Impotence and its medical and psychological correlates: results of the Massachusset Male Aging Study. J Urol 1994;151:54-61.
4. Bortolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997;20:323-334
5. Mombouli J-V, Vanhoutte PM. Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol 1999;31:61-74.
6. De Wit C, Hoepfl B, Wölfle SE. Endothelial mediators and communication through vascular gap junctions. Boil Chem 2006;387:3-9.
7. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-1375
8. Triggle CR, Hollenberg M, Anderson TJ, Ding H, Jiang Y, Ceroni L, et al. The endothelium in health and disease - a target for therapeutic intervention. J Smooth Muscle Res 2003;39:249-267
9. Cardillo C, Campia U, Kilcoyne CM, Bryant MB, Panza JA. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation 2002;105:452-456
10. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 2000;130:963-974
11. Matz RL, Schott C, Stoclet JC, Andriantsitohaina R. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res 2000;49:11-18
12. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126
13. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874
14. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695
15. Hansson GK, Robertson AK, Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu Rev Pathol 2006;1:297-329.
16. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008;8:802-815
17. Johnson JL, Newby AC. Macrophage heterogeneity in atherosclerotic plaques. Curr Opin Lipidol 2009;20:370-378
18. Shimada K. Immune system and atherosclerotic disease. Heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis. Circ J 2009;73:994-1001.
19. Wespes E, Delree P, Hauzeur C, Babar S, Moguilevsky N, Vanhaeverbeek M, et al. Vascular impotence: cavernous endothelial dysfunction rather than an atherosclerosis process! J Urol 2007; 177:263 (abstract).
20. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of atherosclerotic plaque. J Cardiovasc Pharmacol 1995;25:S9-12.
21. Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999;147:235-255
22. Jarvisalo MJ, Juonala J, Raitakari OT. Assessment of inflammatory markers and endothelial function. Curr Opin Clin Nutr Metab Care 2006;9:547-552
23. Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, et al. Early up-regulation of endothelial adhesion molecules in obese hypertensives men. Hypertension 1999; 34:568-573
24. Tatzber F, Rabl H, Koriska K, Erhart U, Puhl H, Waeg G, et al. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis 1991;89:203-208
25. Seong DH, Ryu JK, Song S, Yoon SM, Suh JK. Elevated plasma transforming growth factor-b1 level in patients with vasculogenic erectile dysfunction. Eur Urol Suppl 2001;3(2):31.
26. Bocchio M, Desideri G, Scarpelli P, Necozione S, Properzi G, Spartera C, et al. Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol 2004;171:1601-1604
27. Goldschmidt-Clermont PJ, Creager MA, Lorsordo DW, Lam GKW, Wassef M, Dzau VJ. Atherosclerosis 2005: recent discoveries and novel hypotheses. Circulation 2005;112:3348-3353
28. Werner N, Wassmann S, Ahlers P, Schiegl T, Kosiol S, Link A, et al. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007;102;565-571
29. Boilson BA, Kiernan TJ, Harbuzariu A, Nelson RE, Lerman A, Simari RD. Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. Nat Clin Pract Cardiovasc Med 2008;5:489-496
30. Imanishi T, Moriwaki C, Hano T, Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005;23:1831-1837
31. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005;45:1441-1448
32. Li H, Wallerath T, Förstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 2002;7:132-147
33. Moreland RB, Albadawi H, Bratton C, Patton G, Goldstein I, Traish A, et al. O2-dependent prostanoid synthesis activates functional PGE receptors on corpus cavernosum smooth muscle. Am J Physiol Heart circ Physiol 2001;281:H552-8.
34. Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I. Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest 1993;91:437-442
35. Sattar AA, Noël JC, Vanderhaeghen JJ, Schulman CC, Wespes E. Prostate capsule: computerized morphometric analysis of its components. Urology 1995;46:178-181
36. Sattar AA, Schulman C, Wespes E. Objective quantification of cavernous endothelium in potent and impotent men. J Urol 1995;153:1136-1138
37. Raviv G, Wespes E, Vanegas JP, Petein M, Schulman CC, Kiss R, et al. Difference in glycohistochemical lectin staining of collagen fibers in the corpora cavernosa of normal and impotent men. J Androl 1996;17:187-193
38. Raviv G, Kiss R, Vanegas JP, Petein M, Danguy A, Schulman C, Wespes E. Objective measurement of the different collagen types in the corpus cavernosum of potent and impotent men: an immunohistochemical staining with computerized-image analysis. World J Urol 1997;15:50-55
39. Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the "tip of the iceberg" of a systematic vascular disorder? Eur Urol 2003;44:352-354
40. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A, Rigatti P, Montorsi F. The artery size hypothesis: a macrovascular link between erectile dysfucntion and coronary artery disease. Am J Cardiol 2005;96(suppl):19M-23M.
41. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Blank J. Impaired brachial artery endothelium-dependent and -independent vasodilatation in men with erectile dysfunction and no other clinical cardiovascular disease. JACC 2004;43:179-184
42. Kaya C, Uslu Z, Karaman I. Is endothelial function impaired in erectile dysfunction patients? Int J Impot Res 2006;18(1):55-60.
43. Elesber AA, Solomon H, Lennon RJ, Mathew V, Prasad A, Pumper G, et al. Coronary endothelium dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J 2006;27:824-831
44. Ma RC, So WY, Yang X, Yu LW, Kong AP, Ko GT, et al. Erectile dysfunction predicts coronary artery disease in type 2 diabetes. JACC 2008;51:2045-2050
45. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005;294:2996-3002.
46. Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003;44(3):360-364
47. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Veglia F, Briganti A, et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 2006;27:2632-2639
48. Kawanishi Y, Lee KS, Kimura K, Koizumi T, Nakatsuji H, Kojima K, et al. Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. Int J Impot Res 2001;13:100-103
49. Foresta C, Palego P, Schipilliti M, Selice R, Ferlin A, Caretta N. Asymmetric development of peripheral atherosclerosis in patients with erectile dysfunction: an ultrasonographic study. Atherosclerosis 2008;197:889-895
50. Saltzman EA, Guay AT, Jacobson J. Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004;172:255-258
51. Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, Corradi L. Sexual activity in hypertensive men treated with valsartan and carvedilol: a crossover study. Am J Hypertens 2001;14:27-31.
52. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150-154
53. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004;291:2978-2984
54. Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J, et al. EAU. EAU guidelines on erectile dysfunction: an update. Eur Urol 2006;49:806-815
55. Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL. Can phosphodiesterase type 5 inhibitors cure erectile dysfunction? Eur Urol 2006;49:979-986
56. Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 2007;19:200-207
57. Bocchio M, Pelliccione F, Passaquale G, Mihalca R, Necozione S, Desideri G, et al. Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction. Atherosclerosis 2008;196:313-319